Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT00121836

Public ClinicalTrials.gov record NCT00121836. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Study of Xeloda Plus Avastin at Time of Disease Progression in Treatment-naïve Women With HER2-negative Metastatic Breast Cancer

Study identification

NCT ID
NCT00121836
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
109 participants

Conditions and interventions

Conditions

Interventions

  • Bevacizumab Drug
  • Capecitabine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2005
Primary completion
Nov 30, 2008
Completion
Nov 30, 2008
Last update posted
Apr 26, 2011

2005 – 2008

United States locations

U.S. sites
57
U.S. states
22
U.S. cities
42
Facility City State ZIP Site status
Not listed Birmingham Alabama 35022
Not listed Birmingham Alabama 35205
Not listed Birmingham Alabama 35209
Not listed Birmingham Alabama 35211
Not listed Birmingham Alabama 35213
Not listed Birmingham Alabama 35235
Not listed Burbank California 91505
Not listed Glendale California 91204
Not listed Glendale California 91206
Not listed Los Angeles California 90057
Not listed San Diego California 92121
Not listed Farmington Connecticut 06030
Not listed Bonita Springs Florida 34135
Not listed Boynton Beach Florida 33435
Not listed Bradenton Florida 34209
Not listed Cape Coral Florida 33990
Not listed Fort Myers Florida 33901
Not listed Fort Myers Florida 33908
Not listed Naples Florida 34102
Not listed Naples Florida 34119
Not listed Port Charlotte Florida 33980
Not listed Sarasota Florida 34232
Not listed Sarasota Florida 34236
Not listed Venice Florida 34292
Not listed Atlanta Georgia 30341
Not listed Augusta Georgia 30901
Not listed Tucker Georgia 30084
Not listed Chicago Illinois 60611
Not listed Indianapolis Indiana 46202
Not listed Indianapolis Indiana 46219
Not listed Waterloo Iowa 50702
Not listed Scarborough Maine 04074
Not listed Prince Frederick Maryland 20678
Not listed Lansing Michigan 48909
Not listed Kansas City Missouri 64064
Not listed Kansas City Missouri 64111
Not listed Kansas City Missouri 64131
Not listed Kansas City Missouri 64154
Not listed Kansas City Missouri 66112
Not listed Kansas City Missouri 66210
Not listed Lincoln Nebraska 68510
Not listed Omaha Nebraska 68114
Not listed Las Vegas Nevada 89106
Not listed Brick New Jersey 08724
Not listed Neptune City New Jersey 07754
Not listed Red Bank New Jersey 07701
Not listed Rochester New York 14642
Not listed Hickory North Carolina 28602
Not listed Canton Ohio 44718
Not listed Oklahoma City Oklahoma 73112
Not listed Beaufort South Carolina 29902
Not listed Charleston South Carolina 29406
Not listed Florence South Carolina 29506
Not listed Hilton Head Island South Carolina 29926
Not listed Sumter South Carolina 29150
Not listed Abingdon Virginia 24211
Not listed Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00121836, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2011 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00121836 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →